Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 228410-90-0 | MDL No. : | MFCD06659520 |
Formula : | C6H5BrN2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QXPNHVCGSASGIX-UHFFFAOYSA-N |
M.W : | 233.02 | Pubchem ID : | 21706517 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.55 |
TPSA : | 78.68 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.32 cm/s |
Log Po/w (iLOGP) : | 0.92 |
Log Po/w (XLOGP3) : | 0.57 |
Log Po/w (WLOGP) : | 1.35 |
Log Po/w (MLOGP) : | 0.28 |
Log Po/w (SILICOS-IT) : | 0.52 |
Consensus Log Po/w : | 0.73 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.95 |
Solubility : | 2.63 mg/ml ; 0.0113 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.79 |
Solubility : | 3.74 mg/ml ; 0.016 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.56 |
Solubility : | 0.643 mg/ml ; 0.00276 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.18 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With sulfuric acid; sodium nitrite In water at 0 - 100℃; for 6 h; | To a solution of 5-bromo-4-methyl-3-nitropyridin-2-amine (28 g, 121 mmol) in water (900 ml) was added H2S04 (28 ml) followed by NaN02 (20.91 g, 303 mmol) in water (100 ml) drop wise at 0°C. The reaction mixture was slowly warmed to room temperature for 2h, the reaction mixture was heated at 100°C for 4h. The solid formed in reaction mixture was filtered and dried to afford title compound as a pale yellow solid (24.0 g, 85 percent); 1H NMR (400 MHz, DMSO-de) δ 12.97 (s, 1H), 8.01 (s, 1H), 2.21 (s, 3H); LC/MS: 233 (M+l)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5 h; Stage #2: at 20℃; for 3 h; |
Step 1. 5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one A solution of 5-bromo-4-methyl-3-nitropyridin-2-ol (15.00 g, 64.37 mmol) [Combi-Blocks, AN-1086] in N,N-dimethylformamide (250 mL) was treated with sodium hydride (3.09 g, 77.3 mmol) (60percent dispersion on mineral oil) slowly and portionwise, and stirred at RT for 30 min. The reaction mixture was treated with methyl iodide (4.81 mL, 77.2 mmol) dropwise and stirred at RT for 3 h. LCMS indicated a clean peak for methylated product. The reaction mixture was poured over water/ice (˜400 mL) and allowed to stir while the ice melted. The aqueous mixture was extracted with EA. The organic layer was washed with water (3*) and brine, dried with magnesium sulfate, filtered, and concentrated to give the desired product (14.9 g, 93percent) that was used without further purification. LCMS calculated for C7H8BrN2O3 (M+H)+: m/z=247.0, 249.0. found: 247.0, 248.9. |
93% | Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5 h; Stage #2: at 20℃; for 3 h; |
Step 1. 5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one A solution of 5-bromo-4-methyl-3-nitropyridin-2-ol (15.00 g, 64.37 mmol) [Combi-Blocks, AN-1086] in N,N-dimethylformamide (250 mL) was treated with sodium hydride (3.09 g, 77.3 mmol) (60percent dispersion on mineral oil) slowly and portionwise, and stirred at RT for 30 min. The reaction mixture was treated with methyl iodide (4.81 mL, 77.2 mmol) dropwise and stirred at RT for 3 h. LCMS indicated a clean peak for methylated product. The reaction mixture was poured over water/ice (˜400 mL) and allowed to stir while the ice melted. The aqueous mixture was extracted with ethyl acetate. The organic layer was washed with water (3*) and brine, dried with magnesium sulfate, filtered, and concentrated to give the desired product (14.9 g, 93percent) that was used without further purification. LCMS calculated for C7H8BrN2O3 (M+H)+: m/z=247.0, 249.0. found: 247.0, 248.9. |
92% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; | To a solution of 5-bromo-4-methyl-3-nitropyridin-2-ol (24 g, 103 rnmol) in DMF (200 ml) was added K2CO3 (21.39 g, 155 mmol) and CH3I (21.86 g, 155 mmol). The reaction mixture was stirred at room temperature for 2h. The reaction mixture was poured into ice cold water, the solid formed was filtered and dried under vacuum to afford title compound as off white solid (23.5 g, 92 percent). FontWeight="Bold" FontSize="10" H NMR (400 MHz, DMSO-d6) δ 8.40 (s, 1H), 3.51 (s, 3H), 2.21 (s, 3H). |
[ 1446237-40-6 ]
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
Similarity: 0.96
[ 15862-34-7 ]
5-Bromo-2-hydroxy-3-nitropyridine
Similarity: 0.88
[ 98786-86-8 ]
3-Amino-5-bromopyridin-2(1H)-one
Similarity: 0.71
[ 881-50-5 ]
N-(4-Bromo-2-nitrophenyl)acetamide
Similarity: 0.70
[ 1446237-40-6 ]
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
Similarity: 0.96
[ 15862-34-7 ]
5-Bromo-2-hydroxy-3-nitropyridine
Similarity: 0.88
[ 21901-18-8 ]
4-Methyl-3-nitropyridin-2(1H)-one
Similarity: 0.84
[ 98786-86-8 ]
3-Amino-5-bromopyridin-2(1H)-one
Similarity: 0.71
[ 1446237-40-6 ]
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
Similarity: 0.96
[ 15862-34-7 ]
5-Bromo-2-hydroxy-3-nitropyridine
Similarity: 0.88
[ 21901-18-8 ]
4-Methyl-3-nitropyridin-2(1H)-one
Similarity: 0.84
[ 1446237-40-6 ]
5-Bromo-1,4-dimethyl-3-nitropyridin-2(1H)-one
Similarity: 0.96
[ 15862-34-7 ]
5-Bromo-2-hydroxy-3-nitropyridine
Similarity: 0.88
[ 21901-18-8 ]
4-Methyl-3-nitropyridin-2(1H)-one
Similarity: 0.84
[ 98786-86-8 ]
3-Amino-5-bromopyridin-2(1H)-one
Similarity: 0.71